Premium
Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA‐approved trials
Author(s) -
Weinberg Ido,
Keyes Michelle J.,
Giri Jay,
Rogers Kevin R.,
Olin Jeffrey W.,
White Christopher J.,
Jaff Michael R.
Publication year - 2013
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.25263
Subject(s) - medicine , renal artery , blood pressure , stent , cardiology , revascularization , renovascular hypertension , renal artery stenosis , prospective cohort study , univariate analysis , surgery , kidney , myocardial infarction , multivariate analysis
Background Renal artery stent revascularization is commonly used for renovascular hypertension. Clinical predictors associated with blood pressure (BP) improvement after renal artery stent revascularization are not well understood. Methods Patient‐level data from 901 patients in five prospective multicenter Food and Drug Administration‐approved investigational device exemption studies of renal artery stent revascularization was pooled. BP response was defined as reduction of systolic BP (SBP) by > 10 mm Hg. Stent patency was defined within each study. Associations of BP reduction were determined by logistic regression. Results Of 901 patients, complete outcome information was available in 527. Of these, 212/527 (40%) were male, mean age was 63 ± 13 years, 196/544 (36%) were diabetic and 504/527 (96%) had a SBP ≥ 140 mm Hg or DBP ≥ 90 mm Hg at baseline. Compared to baseline, 9‐month systolic (164 ± 21 mm Hg vs. 146 ± 22 mm Hg, P < 0.0001) and diastolic (79 ± 13 mm Hg vs. 76 ± 12 mm Hg, P < 0.0001) BP declined significantly. Nine‐month stent patency was 90% (305/339). In a univariate analysis, baseline SBP >150 mm Hg (OR = 4.09, CI = 2.74–6.12, P < 0.0001) was positively associated with BP response following renal artery stent revascularization. In a multivariable analysis, baseline SBP remained associated with a positive BP response (OR = 1.76, CI = 1.53–2.03, P < 0.0001). Conclusions In the largest pooled dataset of patients treated with renal artery stent revascularization, SBP and DBP were significantly lower at 9‐months. Elevated baseline SBP (>150 mm Hg) was strongly associated with BP reduction after the procedure. © 2013 Wiley Periodicals, Inc.